YU-CHIEH TSAICHEN-TU WURUEY-LONG HONG2021-03-042021-03-0420051470-2045https://www.scopus.com/inward/record.uri?eid=2-s2.0-28044470068&doi=10.1016%2fS1470-2045%2805%2970468-X&partnerID=40&md5=9279ada0a15a618ddd483ac93b56e385https://scholars.lib.ntu.edu.tw/handle/123456789/550650[SDGs]SDG3celecoxib; cisplatin; doxorubicin; thalidomide; adult; arthralgia; article; cancer adjuvant therapy; cancer control; case report; computer assisted tomography; drug response; hip arthroplasty; human; lung metastasis; lung resection; male; osteosarcoma; priority journal; salvage therapy; thorax radiography; Adult; Anti-Inflammatory Agents, Non-Steroidal; Bone Neoplasms; Drug Resistance, Neoplasm; Drug Therapy, Combination; Hip; Humans; Immunosuppressive Agents; Male; Osteosarcoma; Pyrazoles; Sulfonamides; Thalidomide; Treatment OutcomeResponse of refractory osteosarcoma to thalidomide and celecoxibjournal article10.1016/S1470-2045(05)70468-X163217692-s2.0-28044470068